Ra Capital Management, L.P.'s Net Worth
Ra Capital Management, L.P.'s net worth is estimated to be at least $604,272,549.65 as of 04/20/2024. CoreStreet's estimation of Ra Capital Management, L.P.'s net worth is based on their sale of stock and current holding of stock.
Ra Capital Management, L.P. is Major Shareholder at Boundless Bio Inc. Common Stock. They have executed at least 68 trades of stock as per SEC Form 4 filings. Their most recent trade was for 312,500 units of BOLD stock on 04/02/2024. Their biggest sale was on 09/29/2020 when they sold 80,707 units of Vaxcyte Inc stock for $4,203,220.56. They typically trade 13 times per year.
Total value of insider buys:
- $586,331,931.81
Total value of insider sells:
- $17,940,617.84
Most recent insider trade:
- April 2, 2024
Ra Capital Management, L.P.'s Insider Trading History
| Boundless Bio Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 2, 2024 | Major Shareholder | 312,500 | $16.00 | Buy | $5,000,000.00 |
| Silverback Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 27, 2024 | Director | 505,954 | $9.79 | Buy | $4,953,289.66 |
March 25, 2024 | Director | 437,600 | $9.06 | Buy | $3,964,656.00 |
Sept. 21, 2023 | Director | 2,700,000 | $3.03 | Buy | $8,181,000.00 |
Aug. 29, 2023 | Director | 3,750,000 | $6.20 | Buy | $23,250,000.00 |
| LENZ Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 21, 2024 | Director | 998,009 | $15.03 | Buy | $15,000,075.27 |
| 89bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 4, 2024 | Director | 1,350,000 | $15.35 | Buy | $20,722,500.00 |
March 24, 2023 | Director | 2,461,538 | $16.25 | Buy | $39,999,992.50 |
Oct. 18, 2022 | Director | 1,172,741 | $7.65 | Buy | $8,971,468.65 |
July 1, 2022 | Director | 2,816,900 | $3.55 | Buy | $9,999,995.00 |
June 2, 2021 | Director | 22,138 | $18.77 | Buy | $415,530.26 |
May 28, 2021 | Director | 123,505 | $18.77 | Buy | $2,318,188.85 |
May 26, 2021 | Director | 48,377 | $18.03 | Buy | $872,237.31 |
Sept. 17, 2020 | Director | 1,300,000 | $28.00 | Buy | $36,400,000.00 |
July 8, 2020 | Director | 275,000 | $27.50 | Buy | $7,562,500.00 |
| PepGen Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 9, 2024 | Director | 2,557,593 | $10.64 | Buy | $27,212,789.52 |
| Wave Life Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 11, 2023 | Director | 1,000,000 | $5.00 | Buy | $5,000,000.00 |
June 16, 2022 | Director | 9,480,052 | $2.15 | Buy | $20,382,111.80 |
| Acumen Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 21, 2023 | Director | 5,161,290 | $7.75 | Buy | $39,999,997.50 |
| Janux Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 19, 2023 | Director | 495,008 | $12.46 | Buy | $6,167,799.68 |
| Dice Molecules Holdings LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 29, 2023 | Director | 66,369 | $29.38 | Buy | $1,949,921.22 |
March 27, 2023 | Director | 151,132 | $27.48 | Buy | $4,153,107.36 |
March 23, 2023 | Director | 155,089 | $26.67 | Buy | $4,136,223.63 |
Oct. 17, 2022 | Director | 1,640,000 | $36.50 | Buy | $59,860,000.00 |
| Mineralys Therapeutics Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 14, 2023 | Director | 1,250,000 | $16.00 | Buy | $20,000,000.00 |
| Fulcrum Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 20, 2023 | Major Shareholder | 1,923,076 | $13.00 | Buy | $24,999,988.00 |
Jan. 4, 2023 | Major Shareholder | 180,703 | $7.28 | Buy | $1,315,517.84 |
Dec. 27, 2022 | Major Shareholder | 4,089 | $5.99 | Buy | $24,493.11 |
Dec. 19, 2022 | Major Shareholder | 98,787 | $5.90 | Buy | $582,843.30 |
Dec. 16, 2022 | Major Shareholder | 1,341,420 | $5.42 | Buy | $7,270,496.40 |
Dec. 14, 2022 | Major Shareholder | 824,600 | $5.46 | Buy | $4,502,316.00 |
| Werewolf Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 6, 2023 | Director | 1,853,000 | $2.21 | Buy | $4,095,130.00 |
May 4, 2021 | Director | 1,715,000 | $16.00 | Buy | $27,440,000.00 |
| Imara Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 8, 2022 | Major Shareholder | 10,600 | $3.75 | Buy | $39,750.00 |
Oct. 24, 2022 | Major Shareholder | 26,460 | $3.91 | Buy | $103,458.60 |
Oct. 21, 2022 | Major Shareholder | 48,100 | $3.92 | Buy | $188,552.00 |
Oct. 19, 2022 | Major Shareholder | 125,726 | $3.89 | Buy | $489,074.14 |
Oct. 17, 2022 | Major Shareholder | 145,672 | $3.36 | Buy | $489,457.92 |
| Acrivon Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 17, 2022 | Director | 3,389,500 | $12.50 | Buy | $42,368,750.00 |
| Kala Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 25, 2022 | Major Shareholder | 1,434,509 | $0.42 | Sell | $602,493.78 |
May 23, 2022 | Major Shareholder | 1,250,000 | $0.65 | Sell | $812,500.00 |
| Nkarta Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 26, 2022 | Director | 2,200,000 | $15.00 | Buy | $33,000,000.00 |
| Icosavax Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 28, 2022 | Director | 175,318 | $4.53 | Buy | $794,190.54 |
| Cytek Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 14, 2022 | Director | 342,143 | $12.35 | Buy | $4,225,466.05 |
March 11, 2022 | Director | 337,492 | $12.77 | Buy | $4,309,772.84 |
March 9, 2022 | Director | 40,154 | $12.99 | Buy | $521,600.46 |
March 7, 2022 | Director | 337,901 | $12.61 | Buy | $4,260,931.61 |
March 4, 2022 | Director | 63,662 | $12.99 | Buy | $826,969.38 |
March 2, 2022 | Director | 138,255 | $12.89 | Buy | $1,782,106.95 |
Feb. 28, 2022 | Director | 8,746 | $12.97 | Buy | $113,435.62 |
Feb. 24, 2022 | Director | 186,467 | $13.03 | Buy | $2,429,665.01 |
Feb. 22, 2022 | Director | 214,922 | $13.46 | Buy | $2,892,850.12 |
Feb. 18, 2022 | Director | 166,229 | $14.12 | Buy | $2,347,153.48 |
Feb. 16, 2022 | Director | 166,200 | $14.98 | Buy | $2,489,676.00 |
Feb. 14, 2022 | Director | 166,229 | $14.72 | Buy | $2,446,890.88 |
| Solid Biosciences LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 19, 2021 | Director | 2,206,685 | $5.75 | Buy | $12,688,438.75 |
| Rhythm Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 2, 2020 | Major Shareholder | 30,939 | $32.39 | Sell | $1,002,114.21 |
July 1, 2020 | Major Shareholder | 25,527 | $21.87 | Sell | $558,275.49 |
June 29, 2020 | Major Shareholder | 52,049 | $22.19 | Sell | $1,154,967.31 |
June 25, 2020 | Major Shareholder | 11,568 | $25.05 | Sell | $289,778.40 |
| Pmv Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2020 | Major Shareholder | 950,000 | $18.00 | Buy | $17,100,000.00 |
| Vaxcyte Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2020 | Major Shareholder | 80,707 | $52.08 | Sell | $4,203,220.56 |
| TG Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 9, 2020 | Major Shareholder | 158,589 | $25.81 | Sell | $4,093,182.09 |
| Verastem Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 25, 2020 | Major Shareholder | 1,161,300 | $1.91 | Sell | $2,218,083.00 |
April 27, 2020 | Major Shareholder | 1,301,300 | $2.31 | Sell | $3,006,003.00 |
| Phathom Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 31, 2020 | Major Shareholder | 30,600 | $24.55 | Buy | $751,230.00 |
March 27, 2020 | Major Shareholder | 30,000 | $24.60 | Buy | $738,000.00 |
| Scpharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 14, 2020 | Major Shareholder | 271,993 | $8.20 | Buy | $2,230,342.60 |